Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1997-6-30
|
pubmed:abstractText |
The activation of T cells through presentation of antigen by dendritic cells (DC) relies on many factors, including the correct balance of cytokines in the immediate microenvironment. Antigen presentation by DC migrating from carcinogen-treated skin is impaired as evidenced by the failure of antigen-pulsed DC to initiate specific T cell proliferation. To elucidate mechanism(s) of DC dysfunction, DC migrating from carcinogen-treated skin were collected, pulsed with OVA, and cultured with antigen-specific autologous lymphocytes. Supernatants were assayed for the costimulatory cytokine IL-1 beta which influences the outcome of DC:T cell interactions. The dendritic cells migrating from carcinogen-treated skin that failed to induce T cell proliferation were unable to produce IL-1 beta. This may account for the abrogation of DC function following exposure to chemical carcinogens and provides an explanation for the inability of DC to induce a protective immune response to carcinogen-induced tumours.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/9,10-Dimethyl-1,2-benzanthracene,
http://linkedlifedata.com/resource/pubmed/chemical/Benzo(a)pyrene,
http://linkedlifedata.com/resource/pubmed/chemical/Carcinogens,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Tetradecanoylphorbol Acetate
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0008-8749
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
178
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
17-23
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9184694-9,10-Dimethyl-1,2-benzanthracene,
pubmed-meshheading:9184694-Animals,
pubmed-meshheading:9184694-Antigen Presentation,
pubmed-meshheading:9184694-Benzo(a)pyrene,
pubmed-meshheading:9184694-Carcinogens,
pubmed-meshheading:9184694-Dendritic Cells,
pubmed-meshheading:9184694-Interleukin-1,
pubmed-meshheading:9184694-Lymph,
pubmed-meshheading:9184694-Lymphocyte Activation,
pubmed-meshheading:9184694-Sheep,
pubmed-meshheading:9184694-Skin,
pubmed-meshheading:9184694-T-Lymphocytes,
pubmed-meshheading:9184694-Tetradecanoylphorbol Acetate
|
pubmed:year |
1997
|
pubmed:articleTitle |
Failure of carcinogen-altered dendritic cells to initiate T cell proliferation is associated with reduced IL-1 beta secretion.
|
pubmed:affiliation |
Division of Pathology, University of Tasmania, Hobart, Australia.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|